Production (Stage)
International Stem Cell Corporation
ISCO
$0.1667
$0.01258.11%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -12.96% | 12.25% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -12.96% | 12.25% | |||
| Cost of Revenue | 0.20% | 1.64% | |||
| Gross Profit | -21.91% | 20.83% | |||
| SG&A Expenses | -28.83% | 47.74% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.13% | 5.55% | |||
| Operating Income | -521.57% | 156.67% | |||
| Income Before Tax | -2,427.27% | 108.80% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2,427.27% | 108.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2,427.27% | 108.80% | |||
| EBIT | -521.57% | 156.67% | |||
| EBITDA | -252.38% | 383.78% | |||
| EPS Basic | -2,385.71% | 108.97% | |||
| Normalized Basic EPS | -2,322.22% | 109.18% | |||
| EPS Diluted | -2,385.71% | 108.97% | |||
| Normalized Diluted EPS | -2,322.22% | 109.18% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||